Literature DB >> 10233862

Physiological and cytogenetic characterization of immortalized human endometriotic cells containing episomal simian virus 40 DNA.

A Akoum1, J Lavoie, R Drouin, C Jolicoeur, A Lemay, R Maheux, E W Khandjian.   

Abstract

The study of misplaced endometrial cells, which abnormally implant and grow outside the uterine cavity, is of considerable interest for the understanding of the pathophysiology of endometriosis. However, endometriotic cells, particularly epithelial cells, required for primary cell culture are not easily available. We report here the characterization of an endometriotic cell line immortalized after infection of primary endometriotic cell cultures with simian virus 40. Transformed cells express T-antigen, and blot hybridization analysis showed that the viral genome is present as an episome. Cytogenetic analysis revealed a polyploid karyotype with numerical and structural rearrangements involving mainly the same chromosomes (6, 10, 11, 15, and 17). The cell line has been maintained in culture for over 80 passages and was still proliferating without any noticeable change in the biological properties investigated. Transformed endometriotic cells expressed both progesterone and estradiol receptors and were stimulated by these ovarian hormones to secrete monocyte chemotactic protein-1, a factor that may play an important role in the recruitment and activation of peritoneal macrophages. In addition, this response was enhanced in interleukin-1-treated cells. Taken together, these findings support the view that this cell line may be an interesting tool for the study of the pathophysiology of endometriosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10233862      PMCID: PMC1866565          DOI: 10.1016/S0002-9440(10)65376-X

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  62 in total

1.  Immunocytochemical markerprofile of endometriotic epithelial, endometrial epithelial, and mesothelial cells: a comparative study.

Authors:  R F Kruitwagen; L G Poels; W N Willemsen; P H Jap; I J de Ronde; T G Hanselaar; R Rolland
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1991-10-08       Impact factor: 2.435

2.  SV40 T antigen alone drives karyotype instability that precedes neoplastic transformation of human diploid fibroblasts.

Authors:  F A Ray; D S Peabody; J L Cooper; L S Cram; P M Kraemer
Journal:  J Cell Biochem       Date:  1990-01       Impact factor: 4.429

3.  Simian virus 40 and human malignancy.

Authors:  S C Stenton
Journal:  BMJ       Date:  1998-03-21

4.  Cloning of SV40 genomes from human brain tumors.

Authors:  P Krieg; G Scherer
Journal:  Virology       Date:  1984-10-30       Impact factor: 3.616

5.  Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis.

Authors:  J L Shifren; J F Tseng; C J Zaloudek; I P Ryan; Y G Meng; N Ferrara; R B Jaffe; R N Taylor
Journal:  J Clin Endocrinol Metab       Date:  1996-08       Impact factor: 5.958

6.  Increased monocyte chemotactic protein-1 level and activity in the peripheral blood of women with endometriosis. Le Groupe d'Investigation en Gynécologie.

Authors:  A Akoum; A Lemay; S R McColl; I Paradis; R Maheux
Journal:  Am J Obstet Gynecol       Date:  1996-12       Impact factor: 8.661

7.  Secretion of interleukin-6 by human endometriotic cells and regulation by proinflammatory cytokines and sex steroids.

Authors:  A Akoum; A Lemay; I Paradis; N Rheault; R Maheux
Journal:  Hum Reprod       Date:  1996-10       Impact factor: 6.918

8.  Human endometrial fibroblasts immortalized by simian virus 40 large T antigen differentiate in response to a decidualization stimulus.

Authors:  J J Brosens; S Takeda; C H Acevedo; M P Lewis; P L Kirby; E K Symes; T Krausz; A Purohit; B Gellersen; J O White
Journal:  Endocrinology       Date:  1996-06       Impact factor: 4.736

9.  Altered chromosome 6 in immortal human fibroblasts.

Authors:  K Hubbard-Smith; P Patsalis; J R Pardinas; K K Jha; A S Henderson; H L Ozer
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

10.  Secretion of monocyte chemotactic protein-1 by cytokine-stimulated endometrial cells of women with endometriosis. Le groupe d'investigation en gynécologie.

Authors:  A Akoum; A Lemay; C Brunet; J Hébert
Journal:  Fertil Steril       Date:  1995-02       Impact factor: 7.329

View more
  6 in total

1.  Identification of an invasive, N-cadherin-expressing epithelial cell type in endometriosis using a new cell culture model.

Authors:  A Zeitvogel; R Baumann; A Starzinski-Powitz
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

2.  Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity.

Authors:  M Bocchetta; I Di Resta; A Powers; R Fresco; A Tosolini; J R Testa; H I Pass; P Rizzo; M Carbone
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

3.  Establishment of a conditionally immortalized mouse optic nerve astrocyte line.

Authors:  Yang Liu; Gaurang C Patel; Weiming Mao; Abbot F Clark
Journal:  Exp Eye Res       Date:  2018-07-10       Impact factor: 3.467

4.  Endometriosis: a new cellular and molecular genetic approach for understanding the pathogenesis and evolutivity.

Authors:  Jean Bouquet De Jolinière; Jean Marc Bernard Ayoubi; Luca Gianaroli; Jean Bernard Dubuisson; Jean Gogusev; Anis Feki
Journal:  Front Surg       Date:  2014-05-27

5.  Endometriotic cell culture contamination and authenticity: a source of bias in in vitro research?

Authors:  Andrea Romano; Sofia Xanthoulea; Elisa Giacomini; Bert Delvoux; Eugenia Alleva; Paola Vigano
Journal:  Hum Reprod       Date:  2020-02-29       Impact factor: 6.918

6.  Karyotype alteration generates the neoplastic phenotypes of SV40-infected human and rodent cells.

Authors:  Mathew Bloomfield; Peter Duesberg
Journal:  Mol Cytogenet       Date:  2015-10-22       Impact factor: 2.009

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.